VADS
CA209-9T9 ProNiHN
A FRENCH, PROSPECTIVE, NON-INTERVENTIONAL RESEARCH (NIR) OF NIVOLUMAB IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) PROGRESSING ON OR AFTER PLATINUM-BASED THERAPY
Paris
CHRISTOPHE LE TOURNEAU
Pédiatrie Sarcomes
CombinaiR3
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Paris
VALERIE LAURENCE
Pédiatrie Sarcomes
COTESARC (pédiatrie)
multicentre, open-label, Phase I-II study evaluating the combination of a MEK inhibitor and a PDL1 inhibitor in pediatric and adult patients with locally advanced and/or metastatic soft tissue sarcoma
Paris
ISABELLE AERTS
Pédiatrie Sarcomes
E7080-G000-230 OLIE
A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of;Lenvatinib in Combination with Ifosfamide and Etoposide versus Ifosfamide and Etoposide in;Children, Adolescents and Young Adults with Relapsed or Refractory Osteosarcoma
Paris
ISABELLE AERTS
Sarcomes
J1S-MC-JV01
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Paris
SOPHIE PIPERNO-NEUMANN
Sarcomes
J1S-MC-JV02
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Paris
SOPHIE PIPERNO-NEUMANN
Pédiatrie Sarcomes
SARCOME 13 (Pédiatrie)
Multicentre, Randomised, Phase 2 Trial of Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (Metastatic Osteosarcoma at Diagnosis or Localised Disease With Poor Histological Response)
Paris
HELENE PACQUEMENT